Interviews/Contributions Investor Insights: Louis Cannon, MD of BioStar Capital – why were different (part 1) Shared by Ken Dropiewski on February 28, 2024 More in Interviews/Contributions: Investor Insights: Tasneem Dohadwala I Excelestar Ventures – Investment Stage and Amount June 25, 2025 Investor Insights with Tasneem Dohadwala of Excelestar Ventires: Refining Investment Focus June 4, 2025 Investor Insights: Greg Garfield of KCK MedTech – How does he see 2025 playing out May 2, 2025 Share this story Facebook Twitter LinkedIn